The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a major mediator of cellular Ca2+- signals. CaMKII is a multifunctional protein kinase that participates in a variety of different signaling events, which intriguingly can have opposing signaling outcomes (such as cell death versus survival, proliferation versus cell cycle arrest, and potentiation versus depression of synaptic strength). However, the mechanisms that differentiate between such opposing signaling outcomes mediated by CaMKII are currently unclear. A long-proposed attractive mechanism is differential CaMKII auto-phosphorylation at T286, which renders the kinase partially ?autonomous? (i.e. Ca2+-independent). However, experimental evidence is lacking, and preliminary studies of this proposal led to the alternative hypothesis that differentiation is instead mediated by auto-phosphorylation at T305/306, which prevents Ca2+/CaM binding to the kinase. The specific signaling outcomes studied here are long-term potentiation (LTP) and depression (LTD) of synaptic strength, two opposing forms of Ca2+-dependent synaptic plasticity that are induced by high or low frequency stimulation, respectively, and are thought to underlie learning and memory. Over 22 years of research has firmly linked CaMKII to LTP regulation, while CaMKII requirement in LTD is just emerging (including by the preliminary results of this proposal). Contrary to traditional models, T286 auto-phosphorylation is efficiently induced by both LTP- and LTD-stimuli. By contrast, preliminary results indicate that T305/306 auto- phosphorylation is induced exclusively by LTD- but not LTP-stimuli. Theoretical arguments can be made for the biochemical mechanisms that may underlie such stimulus-dependent differential T305/306 autophosphorylation. However, in contrast to the well-studied T286 auto-phosphorylation, little is currently known about the actual holoenzyme mechanisms governing T305/306 phosphorylation. Another important question is how T305/306 auto-phosphorylation may then lead to the opposing down-stream consequences. Preliminary results indicate that it can cause differential CaMKII substrate selection that should indeed promote LTD and suppress LTP. Thus, this proposal will: (1) determine the holoenzyme mechanism underlying the LTD-specific induction (and LTP-specific suppression) of T305/306 phosphorylation, (2) determine the specific occurance and requirement of T305/306 phosphorylation in LTD, (3) determine the requirement for T305/306 (and T286) phosphorylation in communicating excitatory LTP- or LTD-stimuli to inhibitory synapses, where these stimuli induce plasticity in the opposite direction. The results will provide a new conceptual and mechanistic framework of how a single mediator can be required in signal transduction events with opposing outcomes. A better understanding of the specific mechanism studies here will also have impact on new therapeutic strategies for Angelman Syndrome, where a CaMKII T305/306 hyper-phosphorylation is involved in synaptic and learning dysfunctions.

Public Health Relevance

The regulation of cellular functions is mediated by complex networks of signal transduction events. The importance of understanding these networks is highlighted by the fact that the vast majority of non-antibiotic therapeutic drugs target signaling molecules. One level of complexity is that multifunctional signaling molecules such as CaMKII can mediate opposing signaling outcomes, such as cell death versus survival, promotion versus inhibition of proliferation, or potentiation versus depression of neuronal communication. Thus, rational design of therapeutic strategies requires understanding how to interfere specifically only with a detrimental signaling outcome and not with the opposing beneficial outcome. This project will elucidate the molecular mechanisms by which CaMKII can differentiate between mediating opposing signaling outcomes, specifically in the regulation of neuronal communication. This will impact our understanding of important general signal transduction principles. Specifically, it will elucidate the mechanisms underlying higher brain functions (such as learning and memory) and their pathological impairments (with specific significance for Angelman Syndrome). Better understanding of the mechanisms and physiological functions of this potential drug target will benefit therapy development for various conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS081248-06S1
Application #
9694789
Study Section
Program Officer
Churn, Severn Borden
Project Start
2013-07-01
Project End
2021-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Opazo, Patricio; Viana da Silva, Silvia; Carta, Mario et al. (2018) CaMKII Metaplasticity Drives A? Oligomer-Mediated Synaptotoxicity. Cell Rep 23:3137-3145
Woolfrey, Kevin M; O'Leary, Heather; Goodell, Dayton J et al. (2018) CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression. J Biol Chem 293:1551-1567
Cook, Sarah G; Bourke, Ashley M; O'Leary, Heather et al. (2018) Analysis of the CaMKII? and ? splice-variant distribution among brain regions reveals isoform-specific differences in holoenzyme formation. Sci Rep 8:5448
Goodell, Dayton J; Zaegel, Vincent; Coultrap, Steven J et al. (2017) DAPK1 Mediates LTD by Making CaMKII/GluN2B Binding LTP Specific. Cell Rep 19:2231-2243
Myers, Janette B; Zaegel, Vincent; Coultrap, Steven J et al. (2017) The CaMKII holoenzyme structure in activation-competent conformations. Nat Commun 8:15742
Dosemeci, Ayse; Toy, Dana; Burch, Amelia et al. (2016) CaMKII-mediated displacement of AIDA-1 out of the postsynaptic density core. FEBS Lett 590:2934-9
Goodell, Dayton J; Benke, Tim A; Bayer, K Ulrich (2016) Developmental restoration of LTP deficits in heterozygous CaMKII? KO mice. J Neurophysiol 116:2140-2151
Khan, Shahid; Conte, Ianina; Carter, Tom et al. (2016) Multiple CaMKII Binding Modes to the Actin Cytoskeleton Revealed by Single-Molecule Imaging. Biophys J 111:395-408
Barcomb, Kelsey; Hell, Johannes W; Benke, Tim A et al. (2016) The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength. J Biol Chem 291:16082-9
Barcomb, Kelsey; Goodell, Dayton J; Arnold, Don B et al. (2015) Live imaging of endogenous Ca²?/calmodulin-dependent protein kinase II in neurons reveals that ischemia-related aggregation does not require kinase activity. J Neurochem 135:666-73

Showing the most recent 10 out of 21 publications